MI
Healthcare & Life Sciences
miRdetect
Germanymirdetect.de
miRdetect is a Healthcare & Life Sciences startup based in Germany, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
1
Investors
About miRdetect
Based in Germany, miRdetect is a startup. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
miRdetect develops and provides the M371-Test, a high-sensitivity liquid biopsy test that detects the miR-371a-3p microRNA biomarker in blood for the diagnosis and monitoring of testicular cancer.
Explore miRdetect's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.